↓ Skip to main content

Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera

Overview of attention for article published in PLOS ONE, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users
patent
3 patents
facebook
1 Facebook page

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Published in
PLOS ONE, February 2012
DOI 10.1371/journal.pone.0032383
Pubmed ID
Authors

Min Han, Eric Nagele, Cassandra DeMarshall, Nimish Acharya, Robert Nagele

Abstract

Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and neurological assessments to make a diagnosis. The discovery of definitive blood-borne biomarkers would be a major step towards early and reliable diagnosis. Despite attention devoted to this search, such biomarkers have remained elusive. In the present study, we used human protein microarrays to reveal serum autoantibodies that are differentially expressed among PD and control subjects. The diagnostic significance of each of these autoantibodies was evaluated, resulting in the selection of 10 autoantibody biomarkers that can effectively differentiate PD sera from control sera with a sensitivity of 93.1% and specificity of 100%. PD sera were also distinguishable from sera obtained from Alzheimer's disease, breast cancer, and multiple sclerosis patients with accuracies of 86.0%, 96.6%, and 100%, respectively. Results demonstrate that serum autoantibodies can be used as highly specific and accurate biomarkers for PD diagnosis throughout the course of the disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
Unknown 121 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 18%
Researcher 22 18%
Student > Master 17 14%
Student > Bachelor 12 10%
Student > Postgraduate 8 7%
Other 20 16%
Unknown 21 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 28 23%
Medicine and Dentistry 22 18%
Biochemistry, Genetics and Molecular Biology 15 12%
Neuroscience 12 10%
Immunology and Microbiology 6 5%
Other 15 12%
Unknown 24 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2020.
All research outputs
#1,723,638
of 22,663,150 outputs
Outputs from PLOS ONE
#22,228
of 193,502 outputs
Outputs of similar age
#10,234
of 156,341 outputs
Outputs of similar age from PLOS ONE
#330
of 3,531 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,502 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,341 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 3,531 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.